Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
10d ago
MannKind announces 30-week results from Phase 4 INHALE-3 study
Premium
The Fly
MannKind announces 30-week results from Phase 4 INHALE-3 study
1M ago
MannKind receives clearance in Japan to begin Phase 3 study on Clofazimine
Premium
The Fly
MannKind receives clearance in Japan to begin Phase 3 study on Clofazimine
2M ago
MannKind director Kent Kresa to retire from board
PremiumThe FlyMannKind director Kent Kresa to retire from board
3M ago
MannKind reports Q2 adjusted EPS 5c, consensus 1c
Premium
The Fly
MannKind reports Q2 adjusted EPS 5c, consensus 1c
3M ago
MNKD Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
MNKD Upcoming Earnings Report: What to Expect?
3M ago
Pulmatrix enters cross license agreement with MannKind
PremiumThe FlyPulmatrix enters cross license agreement with MannKind
5M ago
MannKind reports Q1 EPS 5c, consensus 3c
Premium
The Fly
MannKind reports Q1 EPS 5c, consensus 3c
6M ago
MannKind: FDA grants Fast Track designation of Clofazimine Inhalation Suspension
Premium
The Fly
MannKind: FDA grants Fast Track designation of Clofazimine Inhalation Suspension
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100